Obviously, the link between NRP-1 expression on tumor-infiltrating immune cells and their tumor-promoting activity has instigated research in the development of NRP-1-blocking moieties, amongst others, monoclonal antibodies (mAbs) and tumor-penetrating peptides (TPPs). Here, NRP1 is linked to neoplasm.